Trademarkia Logo

Canada

C$
PROFOUNDBIO
FORMALIZED

on 14 Jun 2023

Last Applicant/ Owned by

ProfoundBio (Suzhou) Co., Ltd.

Suite 101&102, Bldg 1, P3A, 1 Xinze Street, SIPSuzhou, 210000

CN

Serial Number

2263724 filed on 14th Jun 2023

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

PROFOUNDBIO

Trademark usage description

chemico-pharmaceutical preparations for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infe Read More

Classification Information


Class [005]
Chemico-pharmaceutical preparations for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases; Chemical preparations for pharmaceutical purposes for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases; Biological preparations for medical purposes for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases; Drugs for medical purposes for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases; Pharmaceutical preparations for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases; tablets for medical purposes for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases; biochemical preparations for medical purposes; plasters for medical purposes; capsules sold empty for pharmaceuticals; Medicines for human purposes for the treatment and diagnosis of cancer, autoimmune diseases, immunologic deficiency syndromes, respiratory infections, topical infections, genetic diseases.


Classification kind code

12

Class [042]
Biomedical research services; clinical trials; development of pharmaceutical preparations and medicines; medical research; pharmaceutical research and development; pharmaceutical research services; research and development in the medical biotechnology field; scientific research for medical purposes in the field of oncology; structural and functional analysis of genomes; testing of pharmaceuticals


Classification kind code

12

Mark Details


Serial Number

2263724

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 8th Jan 2025
Agent Changed
Submitted for opposition 287
on 29th Jun 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 14th Jun 2023
Filed
Submitted for opposition 1
on 14th Jun 2023
Created
Submitted for opposition 31
on 14th Jun 2023
Formalized